Posted on 12/17/18
Alira Health Acquires Clinical Insights
Alira Health, a leading international healthcare and life sciences advisory firm, announced that it has acquired Clinical Insights, a data science organization providing data analytics
Posted on 12/17/18
BIONIK Laboratories Announces Multi-Year Purchase Agreement and Ongoing Relationship with Kindred Hospital Rehabilitation Services
BIONIK Laboratories Corp. (OTCQB: BNKL), a pioneering healthcare company combining artificial intelligence and innovative robotics technology to help individuals from hospital to home regain mobility, today . . .
Posted on 12/17/18
Bristol-Myers Squibb and H3 Biomedicine Announce Research Collaboration
NEW YORK, TOKYO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY), Eisai Co., Ltd. and its U.S.-based precision medicine research & development subsidiary H3 Biomedicine, Inc. . . .
Posted on 12/17/18
Voyager Therapeutics Joins Michael J. Fox Foundation Initiatives and Education Campaigns
CAMBRIDGE, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological . . .
Posted on 12/17/18
Better Buy: Biogen vs. Amgen
If you're looking to invest in big biotech stocks, two top candidates that you'll probably want to consider are Biogen (NASDAQ:BIIB) and Amgen (NASDAQ:AMGN). Amgen is . . .
Posted on 12/14/18
Life Lua Subsidiary Of Life Biosciences Named Fierce Biotech Innovation Award Winner
BOSTON, Dec. 13, 2018 /PRNewswire/ -- Rebecca Willumson, publisher of Fierce Biotech, announced today that Life Lua Technologies Inc., a subsidiary of Life Biosciences Inc., has . . .
Posted on 12/13/18
AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals
WALTHAM, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has entered into a definitive agreement to acquire Perosphere Pharmaceuticals Inc., . . .
Posted on 12/13/18
VBI Vaccines Proposes Public Offering of Common Shares
CAMBRIDGE, Mass., Dec. 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today . . .
Posted on 12/12/18
XenoTherapeutics to Start First Human Trial of Xeno-Skin, a Novel Xenotransplantation Treatment for Severe Burns
FDA clears XenoTherapeutics’ IND application; Massachusetts General Hospital designated as study center for first-in-human trials XenoTherapeutics, a life science company whose mission is to solve the . . .
Posted on 12/12/18
Fresenius Medical Care North America Contributes Record Funding to National Kidney Foundation
Fresenius Medical Care North America (FMCNA), the world's largest provider of dialysis products and services, raised more than $800,000 for the National Kidney Foundation (NKF) centerpiece . . .
Posted on 12/12/18
MEDITECH Customer Avera Health Named Top 10 Most Wired by CHIME
MEDITECH customer Avera Health (Sioux Falls, SD) has been named among the top 10 Most Wired recipients by the College of Healthcare Information Management Executives (CHIME)."Everyone . . .
Posted on 12/12/18
Checkmate Pharmaceuticals Announces CEO Transition and $22 Million Financing
Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat advanced cancer
Posted on 12/12/18
Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, announced today . . .
Posted on 12/12/18
Here's Why Flexion Therapeutics Jumped 20.5% in November
What happenedShares of Flexion Therapeutics (NASDAQ:FLXN) rose over 20% last month, according to data provided by S&P Global Market Intelligence. The business reported third-quarter 2018 earnings . . .
Posted on 12/12/18
Axis Communications Partners with Nemours Children’s Hospital
CHELMSFORD, Mass.--(BUSINESS WIRE)--Axis Communications, the market leader in network video, today announced that Nemours Children’s Hospital in Orlando, Florida has integrated Axis HDTV-resolution network cameras into . . .
Posted on 12/12/18
Ra Pharmaceuticals Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced the pricing of an underwritten public offering of 8,387,097 shares of its common stock, at . . .
Posted on 12/12/18
Buxton Dental Practice Wins DODC Outstanding Design Innovation Award
BUXTON, Maine, Dec. 11, 2018 (GLOBE NEWSWIRE) -- The 2018 Outstanding Design Innovation award, one of the premier honors given out in the Dental Office Design . . .
Posted on 12/12/18
Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing . . .
Posted on 12/11/18
Biohaven Announces Proposed Public Offering of Common Shares
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical?stage biopharmaceutical company with a portfolio of innovative, late?stage product candidates targeting neurological diseases, including rare disorders, today . . .
Posted on 12/11/18
Ra Pharmaceuticals Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq: RARX) (“Ra Pharma”) today announced that it intends to offer and sell, subject to market and other conditions, $100 million . . .
Posted on 12/10/18
MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance
MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway."We are committed to making . . .
Posted on 12/10/18
Lyndra Therapeutics Announces Notice of Allowance on Patent Covering Long-acting Pill
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, which is moving toward making daily pills a thing of the past, today announced a Notice of Allowance from the U.S. Patent . . .
Posted on 12/10/18
Alnylam Announces Settlement of Litigation with Silence Therapeutics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has resolved all litigation worldwide with Silence Therapeutics. The settlement . . .
Posted on 12/7/18
Boston Therapeutics Announces Initiation of Sales of Sugardown in Asia
LAWRENCE, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Boston Therapeutics, Inc. (OTCQB: BTHE), an innovator in the design, development and commercialization of novel therapeutics as an adjunct . . .
Posted on 12/7/18
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical . . .

